Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page
- Check5 days agoChange DetectedAdded related topics Non-alcoholic fatty liver disease and MedlinePlus Genetics in the Related Topics section.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page content no longer includes the term 'Non-alcoholic fatty liver disease' and the related topic 'MedlinePlus Genetics'.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded 'Non-alcoholic fatty liver disease' as a study topic and related topic links (MedlinePlus Genetics); updated publication notes clarify that some content is provided voluntarily and auto-filled from PubMed, with a revision tag to v3.3.2. To avoid being alerted by small changes, set an alert condition below.SummaryDifference0.2%

- Check26 days agoChange DetectedA notice about government funding lapse and potential delays was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedDeleted 'Non-alcoholic fatty liver disease' from the page's condition list and removed the related topic 'MedlinePlus Genetics' from the related topics. This affects how the study is categorized and surfaced for NAFLD/NASH-related searches and related resources.SummaryDifference0.1%

- Check41 days agoChange DetectedUI/layout adjustments were made to the Study Details page, but the study data and listed criteria appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.